Goniothalamin induces cell cycle-specific apoptosis by modulating the redox status in MDA-MB-231 cells
Wen-Ying Chen1, Chin-Chung Wu, Yu-Hsuan Lan
1Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung City, Taiwan.
Abstract:
Goniothalamin, a natural occurring styryl-lactone, is a novel compound with putative anticancer activities. In the present study, the mechanism of action of goniothalamin was further investigated in human breast cancer MDA-MB-231 cells. Goniothalamin treatment of cells significantly induced cell cycle arrest at G(2)/M phase and apoptosis. By means of cell cycle synchronization, the G(2)/M phase cells proved to be the most sensitive fraction to goniothalamin-induced apoptosis. Cells treated with goniothalamin revealed an increase in intracellular reactive oxygen species and a decrease in intracellular free thiol contents. The disruption of intracellular redox balance caused by goniothalamin was associated an enhancement of cdc25C degradation. Furthermore, the antioxidant N-acetylcysteine and the glutathione synthesis inhibitor dl-buthionine-(S, R)-sulfoximine, inhibited and enhanced, respectively, the effects of goniothalamin on cell cycle arrest and apoptosis. Taken together, our result demonstrates for the first time that goniothalamin disrupts intracellular redox balance and induces cdc25C degradation, which in turn causes cell cycle arrest and cell death maximally at G(2)/M phase in MDA-MB-231 cells.
Insights
Goniothalamin, a natural compound, triggers cancer cell death by disrupting redox balance and degrading cdc25C, leading to cell cycle arrest at the G(2)/M phase in breast cancer cells.
Area of Science:
- Natural Product Chemistry
- Molecular Biology
- Cancer Research
Background:
- Goniothalamin is a natural styryl-lactone with potential anticancer properties.
- The precise mechanism of goniothalamin's action in cancer cells requires further elucidation.
Purpose of the Study:
- To investigate the mechanism of action of goniothalamin in human breast cancer MDA-MB-231 cells.
- To determine the role of intracellular redox balance and cdc25C degradation in goniothalamin-induced cytotoxicity.
Main Methods:
- Cell cycle analysis using flow cytometry.
- Measurement of intracellular reactive oxygen species (ROS) and free thiol content.
- Assessment of cdc25C protein levels and degradation.
- Pharmacological manipulation of redox balance using N-acetylcysteine and dl-buthionine-(S,R)-sulfoximine.
Main Results:
- Goniothalamin induced significant cell cycle arrest at the G(2)/M phase and apoptosis in MDA-MB-231 cells.
- Treatment increased intracellular ROS and decreased free thiol content, indicating redox imbalance.
- Goniothalamin enhanced cdc25C degradation, correlating with cell cycle arrest and apoptosis.
- Antioxidant and glutathione synthesis inhibitor modulated goniothalamin's effects on cell cycle and apoptosis.
Conclusions:
- Goniothalamin disrupts intracellular redox balance, leading to cdc25C degradation.
- This mechanism results in cell cycle arrest and apoptosis, primarily at the G(2)/M phase.
- Goniothalamin represents a promising agent for breast cancer therapy, acting via redox-sensitive pathways.
Related Concept Videos
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy


